2 Top Stocks to Double Up On Right Now

Amazon (market cap $2.56 trillion) is positioning AI as a dual strategy—renting cloud compute via AWS and building custom chips—to drive higher-margin growth and embed generative AI and robotics across office and fulfillment operations, potentially reducing headcount needs (management cites up to 600,000 roles by 2033) and trimming substantial operating expenses (the article cites ~$162.75 billion in operating expenses in Q3). The stock trades at a forward P/E of 29. Telehealth operator Hims & Hers posted third-quarter revenue up 49% year-over-year to $600 million, trades at a forward P/E of 48, is investing heavily in marketing, and is in talks with Novo Nordisk to distribute Wegovy products—signaling strong growth momentum but ongoing spending before sustained profitability.

Analysis

Market structure: AI tailwinds create a two-tier winner set — cloud infrastructure (AWS, AMZN) and AI-chip/design ecosystems (NVDA, but also AMZN as a rising in-house chip designer). Telehealth (HIMS) benefits from virtualized spend and a Novo Nordisk (NVO) distribution optionality; incumbents in physical retail and low-margin logistics are likely to see share and pricing pressure. Compute supply tightness (GPU/AI accelerators) suggests sustained semi demand and higher capex, supporting equity risk-premia but pushing near-term commodity/capital-goods inflation.

Risk assessment: Key tail risks are regulatory intervention on AI/labor (antitrust, worker-protection laws), supply-chain chokepoints for advanced nodes, and biotech/regulatory failure (FDA denial of oral Wegovy). Time horizons: immediate (30–90 days) for earnings, AI product launches, and partnership announcements; medium (6–18 months) for measurable margin expansion; long (2–7 years) for deepest productivity/cost saves. Hidden dependencies include HIMS’ reliance on NVO supply/pricing and AMZN’s internal chip yield curves and enterprise LLM adoption rates.

Trade implications: Favor concentrated, risk-managed longs in AMZN (as an AWS + ops-efficiency play) and selective HIMS exposure to capture telehealth + weight-management upside, while shorting exposed brick-and-mortar retail. Options: use 9–12 month AMZN call spreads to cap cost and 12-month HIMS LEAPS paired with shorter-term call sales to fund premium; size total exposure to 3–5% portfolio risk. Cross-asset: tighter corporate spreads and USD strength likely if tech earnings accelerate; watch semis for volatility-led trading opportunities.

Key Decisions for Investors

• Establish a 3% portfolio long position in AMZN using a 9–12 month call spread (buy 1x 20–30% OTM calls, sell nearer-OTM calls) to cap cost; add incremental 1–2% if AMZN trades >5% below its 30-day moving average or AWS gross margin improves by >200 bps in a quarter.
• Allocate 1–2% to HIMS via 12-month LEAPS calls funded by selling 30–60 day calls (covered or naked depending on risk appetite); add up to another 1% only if HIMS reports QoQ revenue growth >30% or announces confirmed Wegovy distribution with NVO within 90 days; trim to zero if subscriber churn exceeds 2% or gross margin compresses >200 bps.
• Implement a pair trade: long AMZN (dollar-weighted) vs short XRT (retail ETF) equal-dollar exposure sized 1–2% of portfolio to capture structural e-commerce share gains; take profits if the spread widens +15% and cut losses if the spread reverses -10%.
• Over the next 90 days, reduce direct exposure to brick-and-mortar retail/logistics (e.g., trim XRT holdings by 20–30%) and rotate 3–5% into cloud/AI-focused equities (AMZN, selective semi names) while capping any single semiconductor (NVDA) position to <2% due to competitive/architecture risk.